CDKN2A and neoplasm: Deletion of CDKN2A, a cell cycle regulator and tumor suppressor, is a known prognostic marker of poor survival in glioblastoma.32 It therefore follows that CDKN2A upregulation as observed in our study was associated with longer OS.